Hematology NewsAll FDA panel members go thumbs up for CTL019 in relapsed/refractory childhood ALLJuly 12, 2017ALLCellular TherapyLeukemia, Myelodysplasia, TransplantationImmuno-oncology
Oncology PracticeVIDEO: Immune therapy effective, durable in treatment-naive melanoma brain metastasesJune 12, 2017MelanomaImmuno-oncologyImmunotherapyCNS/Brain Cancer
Oncology PracticeVIDEO: Immunotherapy ups disease control rate in relapsed mesotheliomaJune 6, 2017Lung CancerImmuno-oncology
Oncology PracticeVIDEO: Combined immunotherapy strategy shows promise in advanced solid tumorsJune 6, 2017Immuno-oncologyImmunotherapy
Oncology PracticeImmune-agonist combo has activity against several tumor typesJune 5, 2017Immuno-oncologyImmunotherapyBreast CancerMelanomaRenal Cell CarcinomaGynecologic CancerGenitourinary Cancer
Oncology PracticeFDA approves pembrolizumab for advanced urothelial carcinomaMay 18, 2017Genitourinary CancerImmuno-oncology
Oncology PracticePembrolizumab shows some activity against advanced endometrial cancerMay 18, 2017Gynecologic CancerImmuno-oncology
Oncology PracticeSalvage chemo for NSCLC more effective after PD-1/PD-L1 inhibitorsMay 15, 2017Lung CancerImmuno-oncology
Oncology PracticeAtezolizumab improves OS in NSCLC with brain metastasesMay 12, 2017Lung CancerNeuro-oncologyImmuno-oncology
Oncology PracticeFDA approves pembrolizumab for first-line advanced NSCLCMay 12, 2017Lung CancerImmunotherapyImmuno-oncology
Oncology PracticeSLE linked to subsequent risk of malignant melanomaMay 11, 2017MelanomaPreventive CareImmuno-oncology
Oncology PracticeFlu shots may spark immune adverse events in PD-1 blockade for NSCLCMay 7, 2017ImmunotherapyLung CancerImmuno-oncology
Hematology NewsPembrolizumab advances in relapsed/refractory classic Hodgkin lymphomaMay 2, 2017Hodgkin LymphomaLymphoma & Plasma Cell DisordersImmuno-oncology
Oncology PracticeDurvalumab approved for advanced urothelial carcinomaMay 2, 2017Genitourinary CancerImmuno-oncology
Oncology PracticeNivolumab boosts 5-year survival in advanced NSCLCApril 6, 2017Lung CancerImmuno-oncology
